Skip to main content
High RiskFDAfda-F-0565-2016OTHER

Celestial Seasonings Roastaroma Herbal Tea Lot code: Best Before 20DEC17 Pack size: 6 retail units (20 count)/ per case

Category
Units Affected
4,180
Recall Date
January 15, 2016
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0565-2016.

Hain Celestial Seasoning is recalling Celestial Seasonings Roastaroma Herbal Tea due to conflicting labeling (some packages state "Gluten Free", although it contains barley.)

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0565-2016.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Hain Celestial Group or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0565-2016.

Hain Celestial Group

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Hain Celestial Group Recall FAQ

Hain Celestial Group is the subject of a beverages safety report: Celestial Seasonings Roastaroma Herbal Tea Lot code: Best Before 20DEC17 Pack size: 6 retail units (20 count)/ per case. The notice was published on January 15, 2016 by the U.S. Food and Drug Administration (FDA). Approximately 4,180 units are potentially affected.